Doraiswamy Vinayak
Chief Scientific Officer
Doraiswamy Vinayak has filed 5 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Jul 30, 2026.
On the most recent filing, Doraiswamy Vinayak is listed as Chief Scientific Officer at AtriCure, Inc. Inside the rolling window, Doraiswamy Vinayak reported no open-market purchases and 3 open-market sales totaling $523K in ATRC. The largest disclosed transaction in the window is a sale of 6,000 ATRC shares on Jul 28, 2026, worth $233K.
Companies traded
Other insiders at ATRC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$523K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Doraiswamy Vinayak made?
Doraiswamy Vinayak has filed 5 SEC Form 4 filings (7 transaction rows) across 1 company since 2026.
Which companies does Doraiswamy Vinayak trade?
Doraiswamy Vinayak has filed SEC Form 4 disclosures for 1 company, including ATRC.
When was Doraiswamy Vinayak's most recent SEC Form 4 filing?
Doraiswamy Vinayak's most recent SEC Form 4 filing on Tracefour is dated Jul 30, 2026.
What is Doraiswamy Vinayak's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Doraiswamy Vinayak is listed as Chief Scientific Officer.
What is Doraiswamy Vinayak's total buy and sell value in the current window?
Inside the rolling retention window, Doraiswamy Vinayak bought $0 and sold $523K based on SEC Form 4 filings.
What was Doraiswamy Vinayak's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,000 ATRC shares on 2026-07-28, worth $233K, per SEC Form 4 filings.